Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

SPOC , SPXA , SPB , SPGZ , AQQSQ , PQDI
Sort by: Date|Relevance

Buzz on the Bullboards: Summer's most talked about stocks

August has been a rough month for North American stock markets, with red days and a lot of flat trading activity. Shares of U.S. banks fell this week after several regional lenders were hit with a credit downgrade. Retailers are stuck with products that aren&CloseCurl...
Jonathon Brown | August 24, 2023 |

Viela Bio Shares Trade Higher After Analyst Issues 'Buy' Recommendation

Shares of Viela Bio Inc. rose 20% after an analyst at H.C. Wainwright & Co. initiated coverage of the stock. This morning, shares of clinical-stage biotechnology firm Viela Bio Inc. (VIE:NASDAQ) , which is focused on pioneering treatments for autoimmune and...
Streetwise Reports | February 19, 2020 |

Trillion-dollar US infrastructure plan will draw in plenty of metal

Donald Trump appears to have torn a page from Ahead of the Herd’s manual for recharging the US economy. In an earlier article we said what the global economy really needs, in this low-growth, spending-stalled environment brought about by the pandemic, is...
Richard (Rick) Mills | June 19, 2020 |

MasterCard (MA): Can it charge past short-term resistance?

Share | Credit card titan MasterCard Incorporated ( NYSE: MA , Stock Forum ) recently rebounded from annual low territory, after sector peer Visa Inc. ( NYSE: V , Stock Forum ) affirmed its forecast for 2010 net revenue growth at the high end of the 11% to 15% rang...
Elizabeth Harrow and Andrea Kramer | October 28, 2012 |

Pulmatrix's Licensing Deal with the JNJ Lung Cancer Initiative Sends Shares Up 100%

Pulmatrix's shares opened 90% higher today after the firm reported that it has signed a kinase inhibitor licensing agreement with the Lung Cancer Initiative at Johnson & Johnson. Prior to the U.S. markets open this morning on the first day of trading in 2020, clinical...
Streetwise Reports | January 3, 2020 |

XPhyto: Outperforming Leading Cannabis Stocks

I recently wrote about an increasingly popular but still mostly overlooked medical cannabis company that is innovating industry-leading transdermal and oral thin film drug delivery systems. ( https://stockhouse.com/opinion/independent-reports/2020/01/08/the-golden-bullet-for-d...
Marc Davis | January 29, 2020 |

E*TRADE Shares Rise 23% on $13 Billion Acquisition by Morgan Stanley

Shares of E*TRADE Financial Corp. reached a new 52-week intraday high price on news that the company entered into a definitive agreement to be acquired by Morgan Stanley for $13 billion in an all stock deal. Early this morning prior to the U.S. markets open,...
Streetwise Reports | February 21, 2020 |

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment

Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. Immuno-pharmaceutical company AIM Imm...
Streetwise Reports | March 10, 2020 |

Buzz on the Bullboards: 3 stocks breaking the silence of a quiet June

“Sell in May and go away” is a theme investors and stock traders know well, and during this quieter month of June ahead of summer, some public Canadian companies have been engaging in serious business. This week, we saw the TSX hit a one-month ...
Jonathon Brown | June 6, 2024 |

Buzz on the Bullboards: Digesting Elections, COVID, Q3, & M&A’s

(Image via Fraser Health.) In five days, the final votes in the presidential election will be cast. New daily COVID-19 cases have spiked and talks between Democrats and the White House on reaching a fiscal stimulus deal before Election Day have stalled yet aga...
Stockhouse Editorial | October 28, 2020 |
1 2 3 4 5 6 7 8